AwardTape · Defense awards · Research and development · Health R&D · W81XWH21C0094
W81XWH21C0094: -$1 definitive contract to Brigham & Womens Hospital Inc
Brigham & Womens Hospital Inc holds a definitive contract from Defense Health Agency with -$1 obligated since Oct 2023 and $386K obligated over its life, against a ceiling of $386K. Latest action Apr 24, 2024.
Usariem magnetic resonance spectroscopy research for electrical transcutaneous stimulation for health and operational stress (ethos)
| PIID | W81XWH21C0094 |
|---|---|
| Type | definitive contract |
| Company | Brigham & Womens Hospital Inc |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Research and development · Health R&D |
| PSC | AN11 HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| NAICS | 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Obligated since Oct 2023 | -$1 |
| Total obligated (lifetime) | $386K |
| Ceiling (base and all options) | $386K |
| Base date | Aug 2, 2021 |
| Latest action | Apr 24, 2024 |
| End date | Aug 1, 2023 |
| Actions since Oct 2023 | 1 |
| Pricing | Cost no fee |
| Competition | Not competed |
| Place of performance | MA |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial